title: Glucose-lowering effects of sulfasalazine in type 2 diabetes.
authors.affiliation: Stanford University School of Medicine, Division of Endocrinology, California, USA.
authors.forename: Romana M
authors.initials: RM
authors.lastname: Haas
authors.forename: Phoebe
authors.initials: P
authors.lastname: Li
authors.forename: James W
authors.initials: JW
authors.lastname: Chu
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001786:Blood Glucose / Q000187:drug effects*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D012460:Sulfasalazine
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D012460:Sulfasalazine